Block J B, Tabbarah H, Isacoff W, Drakes T P
J Dermatol Surg Oncol. 1979 Feb;5(2):118-23. doi: 10.1111/j.1524-4725.1979.tb00624.x.
Satisfactory chemotherapeutic management of malignant melanomas in advanced stages must await development of more active agents and combinations of them than are presently available. The development of entirely new means of treatment by hormones, heat, and adjuvants like amphotericin B may improve the efficacy of currently available agents.
晚期恶性黑色素瘤令人满意的化疗管理必须等待比目前可用的更有效的药物及其组合的开发。通过激素、热以及诸如两性霉素B等佐剂开发全新的治疗方法可能会提高现有药物的疗效。
